A group of leading U.S. and international scientists and clinicians issued a consensus statement today identifying prostate cancer as a public health crisis and endorsing the promise of MRI for improved early detection and treatment. They also highlighted the leadership of the U.S. Congress in introducing legislation to fund research into improving prostate cancer diagnostics.
Convening last week at the annual meeting of the International Society of Magnetic Resonance in Medicine in Stockholm, Sweden, members of the AdMeTech Foundation’s International Prostate Cancer MRI Working Group offered their endorsement after reviewing new and emerging scientific data from major academic institutions in the United States, Europe and Japan. Read More
